Skip to main content

David Ramirez Gomez

Institutions of which they are part

Predoctoral researcher
Gene Therapy at Nervous System
Vall Hebron Institut de Recerca

David Ramirez Gomez

Institutions of which they are part

Predoctoral researcher
Gene Therapy at Nervous System
Vall Hebron Institut de Recerca

Projects

Use of chimeric chronokines for neurodegenerative diseases and cognitive impairments associated with aging

IP: Miguel Chillon Rodriguez
Collaborators: Laia Perez Lasarte, David Ramirez Gomez
Funding agency: Fundació Institut de Recerca HUVH
Funding: 102820.06
Reference: VHIR-PHD-2023-007
Duration: 01/02/2024 - 30/01/2028

Related news

The European Rare Diseases Research Alliance (ERDERA) kicked off this September, with an estimated budget of 380 million euros and the aim of improving the lives of 30 million rare disease patients in Europe and beyond.

This gene therapy protects mice against cognitive deficits associated with aging, improves motor function, and delays the onset of diseases such as amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease.

Over the course of two days, experts presented the latest advances in vectors, different gene modification techniques and their transfer to clinical practice.

Related professionals

Deepak Chauhan

Deepak Chauhan

Postdoctoral researcher
Neurovascular Diseases
Read more
Carole Conforti

Carole Conforti

Research technician
Stroke research
Read more
Trond Aasen

Trond Aasen

Main researcher
Translational Molecular Pathology
Read more
Maria Nazarena Pizzi

Maria Nazarena Pizzi

Senior researcher
Cardiovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.